Cytokinetics (CYTK) Assets (2016 - 2025)
Historic Assets for Cytokinetics (CYTK) over the last 16 years, with Q3 2024 value amounting to $1.4 billion.
- Cytokinetics' Assets rose 9390.13% to $1.4 billion in Q3 2024 from the same period last year, while for Sep 2024 it was $1.4 billion, marking a year-over-year increase of 9390.13%. This contributed to the annual value of $824.3 million for FY2023, which is 1876.86% down from last year.
- According to the latest figures from Q3 2024, Cytokinetics' Assets is $1.4 billion, which was up 9390.13% from $1.5 billion recorded in Q2 2024.
- Cytokinetics' Assets' 5-year high stood at $1.5 billion during Q2 2024, with a 5-year trough of $232.5 million in Q2 2020.
- For the 5-year period, Cytokinetics' Assets averaged around $791.0 million, with its median value being $808.1 million (2024).
- Its Assets has fluctuated over the past 5 years, first soared by 15300.41% in 2020, then tumbled by 3116.72% in 2023.
- Cytokinetics' Assets (Quarter) stood at $533.8 million in 2020, then surged by 57.61% to $841.3 million in 2021, then grew by 20.62% to $1.0 billion in 2022, then decreased by 18.77% to $824.3 million in 2023, then surged by 74.21% to $1.4 billion in 2024.
- Its Assets stands at $1.4 billion for Q3 2024, versus $1.5 billion for Q2 2024 and $808.1 million for Q1 2024.